Service Overview
Pathologist-Directed Biomarker Interpretation
Biomarker testing may include immunohistochemistry and other cancer biomarker pathology methods that help inform diagnostic classification and clinical decision-making. In breast pathology, ER and HER2 testing may be clinically relevant as part of physician-directed care and established reporting workflows.
Ancillary Pathways provides pathologist oversight and diagnostic interpretation so biomarker information is considered alongside microscopic findings, specimen context, clinical history, and treating physician needs.